| Blue silver: a very sensitive colloidal Coomassie G‐250 staining for proteome analysis G Candiano, M Bruschi, L Musante, L Santucci, GM Ghiggeri, ... Electrophoresis 25 (9), 1327-1333, 2004 | 2522 | 2004 |
| The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-β1 G Serini, ML Bochaton-Piallat, P Ropraz, A Geinoz, L Borsi, L Zardi, ... The Journal of cell biology 142 (3), 873-881, 1998 | 1103 | 1998 |
| CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory L Mortara, P Castellani, R Meazza, G Tosi, A De Lerma Barbaro, ... Clinical cancer research 12 (11), 3435-3443, 2006 | 811 | 2006 |
| Design and use of a phage display library: human antibodies with subnanomolar affinity against a marker of angiogenesis eluted from a two-dimensional gel A Pini, F Viti, A Santucci, B Carnemolla, L Zardi, P Neri, D Neri Journal of Biological Chemistry 273 (34), 21769-21776, 1998 | 631 | 1998 |
| Membrane‐type matrix metalloproteinases 1 and 2 exhibit broad‐spectrum proteolytic capacities comparable to many matrix metalloproteinases MP D'ortho, H Will, S Atkinson, G Butler, A Messent, J Gavrilovic, B Smith, ... European journal of biochemistry 250 (3), 751-757, 1997 | 562 | 1997 |
| The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase … V Knäuper, S Cowell, B Smith, C López-Otin, M O'Shea, H Morris, L Zardi, ... Journal of Biological Chemistry 272 (12), 7608-7616, 1997 | 448 | 1997 |
| Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previously unobserved exon. L Zardi, B Carnemolla, A Siri, TE Petersen, G Paolella, G Sebastio, ... The EMBO journal 6 (8), 2337-2342, 1987 | 443 | 1987 |
| Selective targeting of tumoral vasculature: comparison of different formats of an antibody (L19) to the ED‐B domain of fibronectin L Borsi, E Balza, M Bestagno, P Castellani, B Carnemolla, A Biro, ... International journal of cancer 102 (1), 75-85, 2002 | 427 | 2002 |
| A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors. B Carnemolla, E Balza, A Siri, L Zardi, MR Nicotra, A Bigotti, PG Natali The Journal of cell biology 108 (3), 1139-1148, 1989 | 421 | 1989 |
| Targeting by affinity–matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform D Neri, B Carnemolla, A Nissim, A Leprini, G Querzè, E Balza, A Pini, ... Nature biotechnology 15 (12), 1271-1275, 1997 | 401 | 1997 |
| Immunoscintigraphic detection of the ED-B domain of fibronectin, a marker of angiogenesis, in patients with cancer M Santimaria, G Moscatelli, GL Viale, L Giovannoni, G Neri, F Viti, ... Clinical Cancer Research 9 (2), 571-579, 2003 | 397 | 2003 |
| The fibronectin isoform containing the ED‐B oncofetal domain: a marker of angiogenesis P Castellani, G Viale, A Dorcaratto, G Nicolo, J Kaczmarek, G Querze, ... International journal of cancer 59 (5), 612-618, 1994 | 397 | 1994 |
| Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix B Carnemolla, L Borsi, E Balza, P Castellani, R Meazza, A Berndt, ... Blood, The Journal of the American Society of Hematology 99 (5), 1659-1665, 2002 | 364 | 2002 |
| Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature C Halin, S Rondini, F Nilsson, A Berndt, H Kosmehl, L Zardi, D Neri Nature biotechnology 20 (3), 264-269, 2002 | 339 | 2002 |
| Targeted delivery of tissue factor to the ED-B domain of fibronectin, a marker of angiogenesis, mediates the infarction of solid tumors in mice F Nilsson, H Kosmehl, L Zardi, D Neri Cancer research 61 (2), 711-716, 2001 | 316 | 2001 |
| Selective targeted delivery of TNFα to tumor blood vessels L Borsi, E Balza, B Carnemolla, F Sassi, P Castellani, A Berndt, ... Blood 102 (13), 4384-4392, 2003 | 313 | 2003 |
| Increased binding affinity and valence of recombinant antibody fragments lead to improved targeting of tumoral angiogenesis F Viti, L Tarli, L Giovannoni, L Zardi, D Neri Cancer research 59 (2), 347-352, 1999 | 313 | 1999 |
| Differential expression of the ED sequence-containing form of cellular fibronectin in embryonic and adult human tissues T Vartio, L Laitinen, O Närvänen, M Cutolo, LE Thornell, L Zardi, I Virtanen Journal of cell science 88 (4), 419-430, 1987 | 288 | 1987 |
| Fibronectin as target for tumor therapy M Kaspar, L Zardi, D Neri International journal of cancer 118 (6), 1331-1339, 2006 | 285 | 2006 |
| The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of … H Stanton, J Gavrilovic, SJ Atkinson, MP d’Ortho, KM Yamada, L Zardi, ... Journal of cell science 111 (18), 2789-2798, 1998 | 276 | 1998 |
Castellaninatinal cancer institute genoaDirección de correo verificada de istge.it
